Average Co-Inventor Count = 7.49
ph-index = 51
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Vertex Pharmaceuticals, Inc. (99 from 1,141 patents)
2. Bristol-myers Squibb Compnay (2 from 3,657 patents)
3. Bristol-myers Squibb Pharma Company (1 from 234 patents)
102 patents:
1. 12384762 - Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
2. RE50453 - Indole derivatives as CFTR modulators
3. 12324802 - Modulators of cystic fibrosis transmembrane conductance regulator
4. 12319693 - Crystalline forms of CFTR modulators
5. 12269831 - Modulators of cystic fibrosis transmembrane conductance regulator
6. 12258333 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
7. 12168009 - Modulators of cystic fibrosis transmembrane conductance regulator
8. 12122788 - Process of making CFTR modulators
9. 11873300 - Crystalline forms of CFTR modulators
10. 11866450 - Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators
11. 11827627 - N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
12. 11639347 - Modulators of ATP-binding cassette transporters
13. 11591350 - Modulators of cystic fibrosis transmembrane conductance regulator
14. 11584761 - Process of making CFTR modulators
15. 11453655 - Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator